{"id":"W2920968324","doi":"10.1002/cam4.2042","title":"Persistent janus kinase‐signaling in chronic lymphocytic leukemia patients on ibrutinib: Results of a phase I trial","year":2019,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Leukemia and Lymphoma Society of Canada; European Hematology Association; Institute of Cancer Research; Leukemia and Lymphoma Society","keywords":"Ibrutinib; Ruxolitinib; Medicine; Chronic lymphocytic leukemia; Janus kinase; Internal medicine; Tyrosine kinase 2; Bruton's tyrosine kinase; Oncology; Leukemia; Pharmacology; Immunology; Cytokine; Myelofibrosis; Bone marrow; Tyrosine kinase; Receptor","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008644863,0.0003521369,0.001092253,0.0005225894,0.00003934661,0.000006954345,0.0002905068,0.0002120394,0.0008634863],"category_scores_gemma":[0.0008610128,0.0002702755,0.0002175395,0.0007689814,0.0003126199,0.00007206424,0.00008476145,0.0004452422,0.0001068009],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.1471178,"about_ca_system_score_gemma":0.03309433,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006133911,"about_ca_topic_score_gemma":0.00009844259,"domain_scores_codex":[0.9958003,0.0001211963,0.001152976,0.0007440042,0.001430577,0.0007509898],"domain_scores_gemma":[0.9976633,0.0004601309,0.0003470118,0.0008822557,0.0002898686,0.0003574308],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8318298,0.001622046,0.002158171,0.005047326,0.001010321,0.0008990515,0.007872975,0.0148561,0.05622451,0.0001514151,0.01665745,0.06167076],"study_design_scores_gemma":[0.927292,0.01974365,0.0004962038,0.005674583,0.0002316356,0.0000189853,0.0003918574,0.03024593,0.01020183,0.00001008646,0.005405096,0.0002881502],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9878816,0.002272459,0.000002201721,0.0003330771,0.001021523,0.002418306,0.00004583203,0.00004395897,0.005981043],"genre_scores_gemma":[0.9960884,0.0003789918,0.00001504408,0.0004485608,0.001015246,0.0001259881,0.0001418584,0.00005688966,0.001728957],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1140234,"threshold_uncertainty_score":0.999975,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04055665254502011,"score_gpt":0.3564501784535835,"score_spread":0.3158935259085634,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}